Bayesian approach to AUC-guided vancomycin monitoring in Intensive Care Unit and Poison Control Department

Tải xuống

Dữ liệu tải xuống chưa có sẵn.
PDF (English) Download: 7 View: 15

Indexing

CÁC SỐ TỪ 2011-2023
Tạp chí Y Dược Học

Tóm tắt

Objectives: To compare AUC24 values between three vancomycin AUC estimation methods, including Bayesian two-concentration, Bayesian one-concentration, and first-order equations.

Materials and methods: A cross-sectional, retrospective study of 67 medical records of adult patients who received vancomycin therapy drug monitoring based on AUC at the Intensive Care Unit - Poison Control Department, Nguyen Tri Phuong Hospital, from July 2023 to April 2024.

Results: There was high agreement between Bayesian two-concentration and one-concentration methods (r = 0.974, clinical agreement 91%), and Bayesian twoconcentration method and first-order equations (r = 0.968, clinical agreement 83.6%) with a variability of 95% LOA -150.5 to 98.9 (MD = -25.8 mg.h/L) and  95% LOA -99.3 to 175.8 (MD = 38.3 mg.h/L), respectively. The Bayesian one-concentration and first-order equations had lower agreement than the other comparisons (r = 0.927, clinical agreement 80.6%), showing significant variability with 95% LOA -144.4 to 272.5 (MD = 64 mg.h/L).

Conclusion: The Bayesian two-concentration and one-concentration methods demonstrated the highest agreement. The methods which had significant differences need to be considered for their interchangeability in clinical practice.

https://doi.org/10.34071/jmp.2025.6.878
Đã xuất bản 03-01-2026
Toàn văn
PDF (English) Download: 7 View: 15
Ngôn ngữ
Số tạp chí Tập 15 Số 6 (2025)
Phân mục Nghiên cứu
DOI 10.34071/jmp.2025.6.878
Từ khóa AUC, Bayesian, ICU, TDM, vancomycin AUC; Bayesian; ICU; TDM; vancomycin

Creative Commons License

công trình này được cấp phép theo Creative Commons Attribution-phi thương mại-NoDerivatives 4.0 License International .

Bản quyền (c) 2025 Tạp chí Y Dược Huế

Do , T. K. V., Vo , N. M. N., Nguyen , N. M., Le , P. Q. N., Le , B. H., & Vo , T. H. (2026). Bayesian approach to AUC-guided vancomycin monitoring in Intensive Care Unit and Poison Control Department. Tạp Chí Y Dược Huế, 15(6), 20–26. https://doi.org/10.34071/jmp.2025.6.878

Bộ Y tế. Dược thư quốc gia Việt Nam. 3rd ed. 3, editor: Nhà xuất bản Y học 2022.

Rybak M, Lomaestro B, Rotschafer JC, Moellering R, Jr., Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists. 2009;66(1):82-98.

Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious

Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. American journal of health-system pharmacy : AJHP : official journal of the American Society of HealthSystem Pharmacists. 2020;77(11):835-64.

Lizza BD, Raush N, Micek ST. Antibiotic Optimization in the Intensive Care Unit. Seminars in respiratory and critical care medicine. 2022;43(1):125-30.

Patel N, Pai MP, Rodvold KA, Lomaestro B, Drusano GL, Lodise TP. Vancomycin: we can’t get there from here. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011;52(8):969-74.

Pai MP, Neely M, Rodvold KA, Lodise TP. Innovative approaches to optimizing the delivery of vancomycin in individual patients. Advanced drug delivery reviews. 2014;77:50-7.

Stanford Health Care. Vancomycin Dosing Guide 2023 [Available from: https://med.stanford.edu/bugsanddrugs/ guidebook.html?tab=proxy.

Rodvold KA, Blum RA, Fischer JH, Zokufa HZ, Rotschafer JC, Crossley KB, et al. Vancomycin pharmacokinetics in patients with various degrees of renal function. Antimicrobial agents and chemotherapy. 1988;32(6):848-52.

Olney KB, Wallace KL, Mynatt RP, Burgess DS, Grieves K, Willett A, et al. Comparison of Bayesian-derived and first-order analytic equations for calculation of vancomycin area under the curve. Pharmacotherapy. 2022;42(4):28491.

Chavada R, Ghosh N, Sandaradura I, Maley M, Van Hal SJ. Establishment of an AUC0-24 Threshold for Nephrotoxicity Is a Step towards Individualized Vancomycin Dosing for Methicillin-Resistant Staphylococcus aureus Bacteremia. Antimicrobial agents and chemotherapy. 2017;61(5):e02535-16.

Men P, Li HB, Zhai SD, Zhao RS. Association between the AUC0-24/MIC Ratio of Vancomycin and Its Clinical Effectiveness: A Systematic Review and Meta-Analysis. PloS one. 2016;11(1):e0146224.

Bệnh viện Nguyễn Tri Phương. Hướng dẫn theo dõi nồng độ vancomycin trong máu và hiệu chỉnh liều theo AUC/MIC trên người bệnh trưởng thành điều trị nội trú 2023.

Covington EW, Watkins AM. Agreement Between Two-Concentration and One-Concentration Area Under the Curve (AUC) Estimates When Using Bayesian Modeling to Dose Vancomycin in Patients With Obesity. Annals of Pharmacotherapy. 2024;58(5):501-5.